KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

TherapeuticsMD (TXMD) Inventory Average: 2012-2022

Historic Inventory Average for TherapeuticsMD (TXMD) over the last 5 years, with Sep 2022 value amounting to $6.4 million.

  • TherapeuticsMD's Inventory Average fell 13.96% to $6.4 million in Q3 2022 from the same period last year, while for Sep 2022 it was $6.4 million, marking a year-over-year decrease of 13.96%. This contributed to the annual value of $7.8 million for FY2021, which is 21.35% down from last year.
  • TherapeuticsMD's Inventory Average amounted to $6.4 million in Q3 2022, which was down 14.99% from $7.6 million recorded in Q2 2022.
  • TherapeuticsMD's Inventory Average's 5-year high stood at $13.2 million during Q1 2020, with a 5-year trough of $1.6 million in Q1 2018.
  • Over the past 3 years, TherapeuticsMD's median Inventory Average value was $7.6 million (recorded in 2022), while the average stood at $8.3 million.
  • In the last 5 years, TherapeuticsMD's Inventory Average skyrocketed by 323.30% in 2019 and then plummeted by 42.05% in 2021.
  • TherapeuticsMD's Inventory Average (Quarterly) stood at $2.8 million in 2018, then surged by 296.63% to $11.2 million in 2019, then fell by 19.95% to $9.0 million in 2020, then fell by 16.41% to $7.5 million in 2021, then dropped by 13.96% to $6.4 million in 2022.
  • Its Inventory Average stands at $6.4 million for Q3 2022, versus $7.6 million for Q2 2022 and $8.3 million for Q1 2022.